Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sachiko Yanagida"'
Autor:
Naoyuki Ukon, Tatsuya Higashi, Makoto Hosono, Seigo Kinuya, Takahiro Yamada, Sachiko Yanagida, Masao Namba, Yoshihide Nakamura
Publikováno v:
Annals of Nuclear Medicine. 36:695-709
In this manuscript, we present the guideline for use of meta-[211At] astatobenzylguanidine ([211At] MABG), a newly introduced alpha emitting radiopharmaceutical to the up-coming World’s first clinical trial for targeted alpha therapy (TAT) at Fukus
Autor:
Takahiro Yamada, Masao Namba, Sachiko Yanagida, Tadashi Watabe, Yoshihide Nakamura, Makoto Hosono, Seigo Kinuya
Publikováno v:
Annals of Nuclear Medicine. 35:753-766
We present the guideline for use of [211At] sodium astatide (NaAt) for targeted alpha therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and
Autor:
Naoyuki, Ukon, Tatsuya, Higashi, Makoto, Hosono, Seigo, Kinuya, Takahiro, Yamada, Sachiko, Yanagida, Masao, Namba, Yoshihide, Nakamura
Publikováno v:
Annals of nuclear medicine. 36(8)
In this manuscript, we present the guideline for use of meta-[
Autor:
Tadashi, Watabe, Makoto, Hosono, Seigo, Kinuya, Takahiro, Yamada, Sachiko, Yanagida, Masao, Namba, Yoshihide, Nakamura
Publikováno v:
Annals of Nuclear Medicine
We present the guideline for use of [211At] sodium astatide (NaAt) for targeted alpha therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and
Publikováno v:
Annals of Nuclear Medicine
Radium-223 dichloride (Ra-223) is the first targeted alpha therapy approved for the treatment of patients with castration-resistant prostate cancer (CRPC) with bone metastasis. Ra-223 improved overall survival in the international Phase III ALSYMPCA
Autor:
Tomio Inoue, Yoshihide Nakamura, Asami Kitaoka, Hideharu Ikebuchi, Sachiko Yanagida, Takahiro Yamada, Nobutaka Nakamura, Kiyotaka Kojima, Seigo Kinuya, Makoto Hosono, Hiroyasu Sugano, Jun Hatazawa
Publikováno v:
Annals of Nuclear Medicine
Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approv
Autor:
Hideharu Ikebuchi, Sachiko Yanagida, Kiyotaka Kojima, Seigo Kinuya, Takahiro Yamada, Kenta Sakaguchi, Makoto Hosono, Hiroyasu Sugano, Yoshihide Nakamura, Jun Hatazawa
Publikováno v:
Annals of Nuclear Medicine
We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry o
Autor:
Kazuhiro Konno, Sachiko Yanagida, Keigo Shibata, Tadashi Hatano, Tetsuo Iwanaga, Keiichi Nakagawa, Kiyoko Kusakabe, Yoshinori Matoba, Hideharu Ikebuchi, Shoji Tsutsumi
Publikováno v:
RADIOISOTOPES. 58:557-576
Autor:
Kiyoko Kusakabe, Sachiko Yanagida, Kazuhiro Konno, Keigo Shibata, Yoshinori Matoba, Keiichi Nakagawa, Shoji Tsutsumi, Tadashi Hatano, Tetsuo Iwanaga, Hideharu Ikebuchi
Publikováno v:
RADIOISOTOPES. 58:537-556
Autor:
Keigo Shibata, Atsushi Yamamoto, Mitsuru Ito, Seigo Kinuya, Kunihiko Yokoyama, Shinichi Kanaya, Mana Yoshimura, Kazuko Kanaya, Tatsuya Yoneyama, Hideharu Ikebuchi, Takahiro Okamoto, Tatsuya Higashi, Kiyoko Kusakabe, Koji Segawa, Takashi Togawa, Mayuki Uchiyama, Sachiko Yanagida, Koichi Ito, Kiyoshi Koizumi, Hiroshi Shibuya
Publikováno v:
Annals of nuclear medicine. 26(4)
This study was undertaken to measure the radiation exposure level of caregivers following outpatient NaI (I-131) 1,110 MBq therapy for remnant thyroid ablation after total thyroidectomy in patients with differentiated thyroid cancer, and to evaluate